Newswise — Princeton, NJ—August 24, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced confirmation of key scientific sessions for its 7th Asia-Pacific Conference scheduled to begin next week, 3-6 September 2016 in Singapore. The conference will feature three, topical plenary sessions focused on the theme, “Pharmacoeconomics and Outcomes Research in Asia-Pacific: Challenges, Opportunities, and Future Direction.”
Plenary #1: Health Technology Assessment and Health Policy: Recent Developments Across Asia(Sunday, 4 September 2016)This session will explore how health technology assessment (HTA) is becoming essential to help inform evidence-based decisions as health systems in Asia undergo rapid change while struggling to cope with immediate challenges, including the expanding elderly populations, the growing demand for high-quality health care, and the need to address inequitable access to health care. This session will provide insight into the current status of HTA and related health policy in Asia, sharing perspectives and experiences, lessons learned, and future trends. This session will be moderated by Syed Aljunid, MD, PhD, Professor, Health Economics and Public Health Medicine and Head, International Centre for Casemix and Clinical Coding, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia. Speakers will include Visanu Thamlikitkul, MD, Professor, Department of Medicine & Head, Division of Infectious Diseases and Tropical Medicine, Faculty of Medicine Siriraj Hospital and Former Chair, Subcommittee of National List Essential Medicines, Mahidol University, Bangkok, Thailand; Takashi Fukuda, PhD, Director, Department of Health and Welfare Services, National Institute of Public Health, Saitama, Japan; Tae-jin Lee, MPH, PhD, Professor, Health Economics, School of Public Health, Seoul National University and President, Korea Association of Health Economics and Policy, Seoul, South Korea; and Kwong Hoe Ng, Head, Evaluation and Appraisal, Agency for Care Effectiveness, Ministry of Health, Singapore, Singapore.
Plenary #2: Harnessing the Power of Big Data to Make Better Health Care Decisions in the Asia-Pacific Region(Monday, 5 September 2016)This plenary will focus on the big data movement can deliver value in Asia-Pacific. Speakers will discuss both challenges and opportunities while addresses multi-stakeholder perspectives and regional considerations. The plenary will be moderated by Louisa Jorm, PhD, Professor and Director, Centre for Big Data Research in Health, University of New South Wales (UNSW), Sydney, Australia. Speakers include, Christopher Chute, MD, DrPH, Bloomberg Distinguished Professor of Health Informatics, Professor of Medicine, Public Health, and Nursing, and Chief Health Research Information Officer, Johns Hopkins Medicine, Johns Hopkins University, Baltimore, MD, USA; Trish Williams, PhD, Professor and Chair of Digital Health Technologies, Finders University, Adelaide, Australia; and Yoke Sin Chong, PhD, Chief Executive Officer, Integrated Health Information Systems Pte Ltd, Singapore, Singapore.
Plenary #3: Universal Health Coverage—The Affordable Dream in ASEAN: Experiences and Lessons Learned(Tuesday, 6 September 2016)This session will explore the increasing demand for universal health coverage across Association of Southeast Asian Nations (ASEAN) countries. The speakers will discuss the vast diversity in the ASEAN countries that has contributed to the variety of their respective health systems. The plenary will be moderated by Ahmad Fuad Afdhal, PhD, Director, Center for Socio-Economic Studies in Pharmacy, Jakarta, Indonesia. Speakers include, Netnapis Suchonwanich, Former Deputy Secretary General, National Health Security Office (NHSO), Bangkok, Thailand; Syed Aljunid, MD, PhD, Professor, Health Economics and Public Health Medicine and Head, International Centre for Casemix and Clinical Coding, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia; Kun Zhao, MD, PhD, MHSc, Professor and Director, Division of Health Policy Evaluation and Technology Assessment, China National Health Development Research Center, National Health and Family Planning Commission (NHFPC), Beijing, China; and Graham Harrison, PhD, World Health Organization Representative to Malaysia, Brunei Darussalam and Singapore, World Health Organization (WHO), Kuala Lumpur, Malaysia.
Registration for ISPOR Singapore is open throughout the conference. In addition to the three plenaries, the conference will feature 15 issue panels, 15 workshops, 5 forums, 40 podium presentations, and 136 poster presentations. The ISPOR Short Course Program will be offered immediately prior to the conference on 3-4 September, 2016 offering 18 courses over seven tracks. Additional information on the conference can be found here.
ABOUT ISPORThe International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ISPOR.org | LinkedIn: www.bit.ly/ISPOR-IN | Twitter: www.bit.ly/ISPOR-T (@ISPORorg) | YouTube: www.bit.ly/ISPOR-YT |Facebook: www.bit.ly/ISPOR-FB